US2010009438A1PendingUtilityA1

Dendritic cell potentiation

75
Individually held — no corporate assignee on recordPriority: Jul 16, 2002Filed: Aug 14, 2009Published: Jan 14, 2010
Est. expiryJul 16, 2022(expired)· nominal 20-yr term from priority
Inventors:Larry R. PeaseMoses RodriguezDaren R. UreLoc T. NguyenSuresh Radhakrishnan
A61K 38/00C07K 2317/74A61P 37/00C07K 14/4705C07K 17/00C07K 14/465C07K 2317/21C07K 2317/52A61K 2039/505Y10S424/808C07K 14/70503C07K 16/2827A61K 40/421A61K 40/24A61K 40/19A61K 40/11A61K 40/00A61K 39/00
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.

Claims

exact text as granted — not AI-modified
1 . A nucleic acid encoding a polypeptide comprising the amino acid sequence set forth in SEQ ID NO:3 or SEQ ID NO:4. 
     
     
         2 . The nucleic acid of  claim 1 , wherein the polypeptide is an immunoglobulin variable chain. 
     
     
         3 . The nucleic acid of  claim 2 , wherein the polypeptide is an immunoglobulin variable heavy chain. 
     
     
         4 . The nucleic acid of  claim 2 , wherein the polypeptide is an immunoglobulin variable light chain. 
     
     
         5 . A vector comprising the nucleic acid of  claim 1 . 
     
     
         6 . A host cell comprising the vector of  claim 5 .

Join the waitlist — get patent alerts

Track US2010009438A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.